275 related articles for article (PubMed ID: 26451612)
1. A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy.
Sánchez-Martínez R; Cruz-Gil S; Gómez de Cedrón M; Álvarez-Fernández M; Vargas T; Molina S; García B; Herranz J; Moreno-Rubio J; Reglero G; Pérez-Moreno M; Feliu J; Malumbres M; Ramírez de Molina A
Oncotarget; 2015 Nov; 6(36):38719-36. PubMed ID: 26451612
[TBL] [Abstract][Full Text] [Related]
2. Targeting the lipid metabolic axis
Cruz-Gil S; Sanchez-Martinez R; Gomez de Cedron M; Martin-Hernandez R; Vargas T; Molina S; Herranz J; Davalos A; Reglero G; Ramirez de Molina A
J Lipid Res; 2018 Jan; 59(1):14-24. PubMed ID: 29074607
[TBL] [Abstract][Full Text] [Related]
3. Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells.
Sánchez-Martínez R; Cruz-Gil S; García-Álvarez MS; Reglero G; Ramírez de Molina A
Sci Rep; 2017 Sep; 7(1):11143. PubMed ID: 28894242
[TBL] [Abstract][Full Text] [Related]
4. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
5. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.
Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897
[TBL] [Abstract][Full Text] [Related]
6. Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration.
Liao C; Li M; Li X; Li N; Zhao X; Wang X; Song Y; Quan J; Cheng C; Liu J; Bode AM; Cao Y; Luo X
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158540. PubMed ID: 31678511
[TBL] [Abstract][Full Text] [Related]
7. Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer.
Ye F; Chen Y; Xia L; Lian J; Yang S
Biochem Biophys Res Commun; 2018 Mar; 497(2):639-645. PubMed ID: 29453983
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer.
Yu CY; Chang WC; Zheng JH; Hung WH; Cho EC
Biochem Biophys Res Commun; 2018 Dec; 506(4):901-906. PubMed ID: 30392905
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
10. CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition.
Kapur N; Mir H; Clark Iii CE; Krishnamurti U; Beech DJ; Lillard JW; Singh S
Br J Cancer; 2016 Jun; 114(12):1343-51. PubMed ID: 27149649
[TBL] [Abstract][Full Text] [Related]
11. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
12. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Beclin-1 impairs epithelial-mesenchymal transition of colon cancer cells.
Shen H; Yin L; Deng G; Guo C; Han Y; Li Y; Cai C; Fu Y; Liu S; Zeng S
J Cell Biochem; 2018 Aug; 119(8):7022-7031. PubMed ID: 29738069
[TBL] [Abstract][Full Text] [Related]
14. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
[TBL] [Abstract][Full Text] [Related]
15. Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer.
Gao F; Huang W; Zhang Y; Tang S; Zheng L; Ma F; Wang Y; Tang H; Li X
Oncotarget; 2015 Nov; 6(36):38667-80. PubMed ID: 26452029
[TBL] [Abstract][Full Text] [Related]
16. ISLR affects colon cancer progression by regulating the epithelial-mesenchymal transition signaling pathway.
Chi C; Liu T; Yang S; Wang B; Han W; Li J
Anticancer Drugs; 2022 Jan; 33(1):e670-e679. PubMed ID: 34520435
[TBL] [Abstract][Full Text] [Related]
17. Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells.
Andreolas C; Kalogeropoulou M; Voulgari A; Pintzas A
Int J Cancer; 2008 Apr; 122(8):1745-56. PubMed ID: 18098284
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
[TBL] [Abstract][Full Text] [Related]
19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer.
Wu ZH; Wang XL; Tang HM; Jiang T; Chen J; Lu S; Qiu GQ; Peng ZH; Yan DW
Oncol Rep; 2014 Jul; 32(1):395-402. PubMed ID: 24840737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
